History of U.S. military contributions to the study of malaria

Military Medicine

Volumn 170, Issue 4 SUPPL., 2005, Pages 12-16

  Ockenhouse, Christian F ^a   Magill, Alan ^a   Smith, Dale ^b   Milhous, Wil ^a  

^a WALTER REED ARMY INSTITUTE OF RESEARCH   (United States)

^b UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

8 AMINOQUINOLINE DERIVATIVE; AMINOACRIDINE; AMODIAQUINE; ARTESUNATE; AZITHROMYCIN; CHLOROQUINE; DAPSONE; DOXYCYCLINE; FANSIDAR; HALOFANTRINE; MALARIA VACCINE; MEFLOQUINE; MEPACRINE; PRIMAQUINE; PROGUANIL; PYRIMETHAMINE; QUININE; QUININE DERIVATIVE; TAFENOQUINE;

AGRANULOCYTOSIS; CLINICAL TRIAL; CONFERENCE PAPER; GENOMICS; HISTORY OF MEDICINE; HUMAN; MALARIA; MALARIA CONTROL; METHEMOGLOBINEMIA; MORTALITY; MOSQUITO; PLASMODIUM VIVAX; PROPHYLAXIS; SOLDIER; STEVENS JOHNSON SYNDROME; UNITED STATES; WAR;

EID: 17444388515     PISSN: 00264075     EISSN: None     Source Type: Journal    
DOI: 10.7205/MILMED.170.4S.12     Document Type: Conference Paper

References (28)

1. Smith DC: Quinine and fever: the development of the effective dosage. J Hist Med 1976; 31: 343-67.
2. Rocco F: The Miraculous Fever-Tree. New York, HarperCollins, 2003.
3. Smith DC, Sanford L: Laveran's germ: the reception and use of a medical discovery. Am J Trop Med Hyg 1985; 34: 2-20.
4. Smith DC: The rise and fall of typhomalarial fever. J Hist Med 1982; 37: 182-220, 287-321.
5. Harrison G: Mosquitoes, Malaria, and Man, pp 157-68. New York, NY, E.P. Dutton, 1978.
6. Russell PF: Man's Mastery of Malaria, p 138. London, Oxford University Press, 1955.
7. Cline D: Skeeter Beaters. Elk River, MN, DeForest Press, 2002.
8. Gahan JB, Travis BV, Morton PA, Lindquist AW: DDT as a residual-type treatment to control Anopheles quadrimaculatus: practical tests. J Econ Entomol 1945; 38: 251-35.
9. Soper FL, Knipe FW, Casini G: Reduction of Anopheles density effected by the pre-season spraying of building interiors with DDT in kerosene, at Castel Volturno, Italy, in 1944-45 and in the Tiber Delta in 1945. Am J Trop Med 1947; 27: 177-200.
10. Garrison PL, Hankey DD, Walter GC: Cure of Korean vivax malaria with pamaquine and primaquine. JAMA 1952; 149: 1562-3.
11. Ognibene AJ: Agranulocytosis due to dapsone. Ann Intern Med 1970; 72: 521-4.
12. Pang L, Limsomwong N, Singharaj P: Prophylactic treatment of vivax and falciparum malaria with low-dose doxycycline. J Infect Dis 1988; 158: 1124-7.
13. Pang LW, Limsomwong N, Boudreau EF: Doxycycline prophylaxis for falciparum malaria. Lancet 1987; 1: 1161-4.
14. Baird JK, Fryauff DJ, Basri H: Primaquine for prophylaxis against malaria among nonimmune transmigrants in Irian Jaya, Indonesia. Am J Trop Med Hyg 1995; 52: 479-84.
15. Fryauff DJ, Baird JK, Basri H: Randomised placebo-controlled trial of primaquine for prophylaxis of falciparum and vivax malaria. Lancet 1995; 346: 1190-3.
16. Andersen SL, Oloo AJ, Gordon DM: Successful double-blinded, randomized, placebo-controlled field trial of azithromycin and doxycycline as prophylaxis for malaria in western Kenya. Clin Infect Dis 1998; 26: 146-50.
17. Shanks GD, Oloo AJ, Aleman GM: A new primaquine analogue, tafenoquine (WR 238605), for prophylaxis against Plasmodium falciparum malaria. Clin Infect Dis 2001; 33: 1968-74.
18. Young JF, Hockmeyer WT, Gross M: Expression of Plasmodium falciparum circumsporozoite proteins in Escherichia coli for potential use in a human malaria vaccine. Science 1985; 228: 958-62.
19. Ballou WR, Hoffman SL, Sherwood JA: Safety and efficacy of a recombinant DNA Plasmodium falciparum sporozoite vaccine. Lancet 1987; 1: 1277-81.
20. Ockenhouse CF, Sun PF, Lanar DE: Phase I/IIa safety, immunogenicity, and efficacy trial of NYVAC-Pf7, a pox-vectored, multiantigen, multistage vaccine candidate for Plasmodium falciparum malaria. J Infect Dis 1998; 177: 1664-73.
21. Nosten F, Luxemburger C, Kyle DE: Randomised double-blind placebo-controlled trial of SPf66 malaria vaccine in children in northwestern Thailand: Shoklo SPf66 Malaria Vaccine Trial Group. Lancet 1996; 348: 701-7.
22. Wang R, Doolan DL, Le TP: Induction of antigen-specific cytotoxic T lymphocytes in humans by a malaria DNA vaccine. Science 1998; 282: 476-80.
23. Stoute JA, Slaoui M, Heppner DG: A preliminary evaluation of a recombinant circumsporozoite protein vaccine against Plasmodium falciparum malaria: RTS,S Malaria Vaccine Evaluation Group. N Engl J Med 1997; 336: 86-91.
24. Haynes JD, Diggs CL, Hines FA: Culture of human malaria parasites Plasmodium falciparum. Nature 1976; 263: 767-9.
25. Gardner MJ, Hall N, Fung E: Genome sequence of the human malaria parasite Plasmodium falciparum. Nature 2002; 419: 498-511.
26. Carlton JM, Angiuoli SV, Suh BB: Genome sequence and comparative analysis of the model rodent malaria parasite Plasmodium yoelii. Nature 2002; 419: 512-9.
27. Florens L, Washburn MP, Raine JD: A proteomic view of the Plasmodium falciparum life cycle. Nature 2002; 419: 520-6.
28. Le Roch KG, Zhou Y, Blair PL: Discovery of gene function by expression profiling of the malaria parasite life cycle. Science 2003; 301: 1503-8.